How the Shingles Vaccine Could Save Your Heart
- Eric Han
- 6 hours ago
- 2 min read
We have long known that the shingles vaccine is the gold standard for preventing the painful, blistering rash caused by the reactivation of the varicella-zoster virus. However, research presented at the American College of Cardiology’s Annual Scientific Session (ACC.26) last month suggests the vaccine’s benefits go far beyond the skin.
For those living with heart disease, the shingles vaccine may be one of the most significant interventions available for preventing major cardiovascular events.
The Study: A 46% Reduction in Major Cardiac Events
Researchers analyzed the health records of over 246,000 U.S. adults with atherosclerotic cardiovascular disease (plaque buildup in the arteries). The study compared those who received at least one dose of a shingles vaccine (Shingrix or Zostavax) against a matched group of unvaccinated individuals.
The results, tracked over the course of one year, were staggering. Vaccination was associated with:
46% lower risk of major adverse cardiovascular events.
27% lower risk of heart attack.
27% lower risk of stroke.
33% lower risk of heart failure.
61% lower risk of death from any cause.
To put this in perspective, experts note that these reductions are comparable to the health benefits seen when a person quits smoking.
Why Does a Shingles Vaccine Protect the Heart?
It may seem strange that a virus associated with chickenpox could impact your heart, but the connection lies in inflammation.
When the shingles virus reactivates, it doesn’t just cause a rash; it triggers systemic inflammation and increases the risk of dangerous blood clots. Previous studies have shown that a shingles infection can increase the risk of a stroke or heart attack by nearly 30%.
By preventing the infection entirely, the vaccine eliminates this inflammatory trigger, effectively shielding the cardiovascular system from a "spike" in risk.
Who Should Prioritize the Vaccine?
The CDC currently recommends two doses of the Shingrix vaccine for:
All adults aged 50 and older.
Adults 19 and older with weakened immune systems.
While these guidelines have been in place for years, this new data provides a compelling reason for patients with existing heart disease to move shingles vaccination to the top of their priority list.
The Woodside MD Perspective
In our Executive Health and Concierge models, we look at vaccines not just as "routine shots," but as strategic tools for longevity. When we conduct your assessment, we review your cardiovascular risk profile in detail. If you have established plaque or a history of heart issues, ensuring you are vaccinated against shingles becomes a critical part of your proactive oversight plan.
Our goal is to reduce every possible inflammatory trigger in your body. Whether it’s managing lipids or staying current on vaccinations, we act as your dedicated medical advocate.
Serving Our Community
We provide this level of comprehensive, proactive primary care to individuals and families throughout Carmel, Zionsville, Westfield, Fishers, and Indianapolis. If you are over 50 and haven't completed your two-dose Shingrix series, or if you have concerns about your cardiovascular health, let's discuss how this simple intervention can protect your heart during your next visit.
Disclaimer: This blog is for informational purposes only and does not constitute medical advice. While this observational study is promising, more research is necessary to confirm a direct cause-and-effect relationship. Always consult with your physician regarding vaccinations.